FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Andrea Merz

Research Profile

Living Beings

Concepts & Ideas

Anatomy

Livers

Chemicals & Drugs

Physiology

Drug Interactions

Procedures

Xenograft Model Antitumor Assays

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Erica L Bradshaw-Pierce; S Gail Eckhardt; Daniel L Gustafson; Gillian Kulikowski; Andrea L Merz; Todd M Pitts; Heather Selby; Natalie J Serkova; Colin D Weekes
Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancer.
Daniel L Gustafson; Barbara Frederick; Andrea L Merz; David Raben
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts.
Daniel L Gustafson; Erica L Bradshaw-Pierce; Andrea L Merz; Joseph A Zirrolli
Tissue distribution and metabolism of the tyrosine kinase inhibitor ZD6474 (Zactima) in tumor-bearing nude mice following oral dosing.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Andrea Merz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Erica L Bradshaw-Pierce; S Gail Eckhardt; Daniel L Gustafson; Gillian Kulikowski; Andrea L Merz; Todd M Pitts; Heather Selby; Natalie J Serkova; Colin D Weekes
Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancer.
PloS one 2013;8(3):e58089.
2008: Daniel L Gustafson; Barbara Frederick; Andrea L Merz; David Raben
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts.
Cancer chemotherapy and pharmacology 2008;61(2):179-88.
2006: Daniel L Gustafson; Erica L Bradshaw-Pierce; Andrea L Merz; Joseph A Zirrolli
Tissue distribution and metabolism of the tyrosine kinase inhibitor ZD6474 (Zactima) in tumor-bearing nude mice following oral dosing.
The Journal of pharmacology and experimental therapeutics 2006;318(2):872-80.
2005: Daniel L Gustafson; Michael E Long; Erica L Bradshaw; Andrea L Merz; Patrick J Kerzic
P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing.
Cancer chemotherapy and pharmacology 2005;56(3):248-54.
2005: Daniel L Gustafson; Andrea L Merz; Michael E Long
Pharmacokinetics of combined doxorubicin and paclitaxel in mice.
Cancer letters 2005;220(2):161-9.
2003: Daniel L Gustafson; David Siegel; Jeffrey C Rastatter; Andrea L Merz; Jacqueline C Parpal; Jadwiga K Kepa; David Ross; Michael E Long
Kinetics of NAD(P)H:quinone oxidoreductase I (NQO1) inhibition by mitomycin C in vitro and in vivo.
The Journal of pharmacology and experimental therapeutics 2003;305(3):1079-86.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.